Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Epilepsia|January 6, 2011
Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancyIlse Wegner, Peter Edelbroek, Gerrit-Jan de Haan, et al.
Reproductive Toxicology (Elmsford, N.Y.)|April 6, 2005
Levetiracetam use and pregnancy outcomeKlara ten Berg, E Bettina Samrén, A Carla van Oppen, et al.
Familial Cancer|September 9, 2011
A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counsellingAkke Albada, Sandra van Dulmen, Dick Lindhout, et al.
Epilepsia|July 16, 2013
Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registryDina Battino, Torbjörn Tomson, Erminio Bonizzoni, et al.
Epilepsy & Behavior : E&B|July 22, 2018
Exposure to antiepileptic drugs in pregnancy: The need for a family factor frameworkYfke Huber-Mollema, Loretta van Iterson, Josemir W Sander, et al.
The Lancet. Neurology|June 10, 2011
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registryTorbjörn Tomson, Dina Battino, Erminio Bonizzoni, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 11, 2019
Fetal methotrexate syndrome: A systematic review of case reportsEline A Verberne, Emma de Haan, J Peter van Tintelen, et al.
Epilepsia|March 4, 2010
Pregnancy registries: differences, similarities, and possible harmonizationTorbjörn Tomson, Dina Battino, John Craig, et al.
Epilepsia|March 5, 2011
Adults with a history of possible Dravet syndrome: an illustration of the importance of analysis of the SCN1A geneNienke E Verbeek, Marjan van Kempen, W Boudewijn Gunning, et al.
The Lancet. Neurology|April 23, 2018
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registryTorbjörn Tomson, Dina Battino, Erminio Bonizzoni, et al.
Pageof 8